
ENROLL TODAY
Register now to gain access to this course.
Activity Overview Medical Crossfire one of PERs signature educational formats is a video based program in which a panel of distinguished experts engage in spirted discussions about a clinical topic In this activity four thought leaders explore the emerging data surrounding sustained delivery anti vascular endothelial growth factor Anti VEGF therapies for the management of neovascular retinal diseases like neovascular age related macular degeneration nAMD This lively debate will place new developments into clinical context to help you optimize care for patients with neovascular retinal diseases Acknowledgement of Commercial Support This activity is supported by an educational grant from Genentech member of the Roche Group Instructions for This Activity andReceiving Credit Complete the activity including pre and post activity assessments Answer the evaluation questions Request credit using the drop down menu You may immediately download your certificate Target Audience This online educational activity is directed toward ophthalmologists and retinal specialists Other health care professionals involved in the treatment of patients with nAMD are also invited to participate Learning Objectives Upon successful completion of this activity you should be better prepared to Discuss the unmet clinical needs for durable sustained treatment options for patients with AMD Analyze the efficacy and safety data for novel sustained delivery options of anti VEGF therapies for the treatment of AMD Incorporate novel sustained delivery options of anti VEGF therapies into management plans for patients with AMD Faculty Staff and Planners Disclosures The staff of Physicians Education Resource LLC have no relevant financial relationships with ineligible entities Chair Arshad M Khanani MD MA Clinical Associate Professor University of Nevada Reno School of Medicine Managing Partner Director of Clinical Research Director of Fellowship Sierra Eye Associates Reno NV Disclosures Grant Research Support Genentech Inc Adverum Biotechnologies Regenxbio Inc Consultant Genentech Adverum Biotechnologies Regenxbio Inc Speakers Bureau Genentech Inc Faculty Sophie J Bakri MD Chair Department of Ophthalmology Mayo Clinic Rochester MN Disclosures Consultant Adverum Biotechnologies Allergan plc Alimera Sciences Inc Apellis Pharmaceuticals Kala Pharmaceuticals Inc Novartis Outlook Therapeutics Inc F Hoffmann La Roche AG Regenexbio Inc Re Vana Therapeutics Ltd Zeiss Pharma Ltd Peter K Kaiser MD Professor of Ophthalmology Chaney Family Endowed Chair in Ophthalmology Research Cleveland Clinic Lerner College of Medicine Cole Eye Institute Cleveland OH Disclosures Consultant Allergan plc Kanghong Pharmaceutical Regeneron Pharmaceuticals Bayer Corporation Novartis Pharmaceuticals Kodiak Sciences Carl D Regillo MD Professor of Ophthalmology Thomas Jefferson University Chief Retina Service WillsEye Hospital Philadelphia PA Disclosures Grant Research Support Adverum Biotechnologies Allergan plc Annexon Biosciences Astellas Pharma Inc Chengdu Kanghong Pharma EyePoint Pharmaceuticals Inc Graybug Vision Iveric Bio Kodiak Sciences Inc Lineage Cell Therapeutics NGM Biopharmaceuticals Inc Notal Vision Novartis Pharmaceuticals Opthea Ltd Regeneron Pharmaceuticals RegenXBio Inc Consultant Adverum Biotechnologies Alderya Therapeutics Allergan plc Annexon Biosciences Aviceda Therapeutics Chengdu Kanghong Pharma Eyepoint Pharmaceuticals Inc Genentech Inc Graybug Vision Iveric Bio Kodiak Sciences Inc Lineage Cell Therapeutics Merck Co NGM Biopharmaceuticals Inc Notal Vision Novartis Pharmaceuticals Ocugen Inc Opthea Ltd Stealth BioTherapeutics Takeda Pharmaceutical Company Limited Tha Pharmaceuticals Limited Zeiss Pharma Ltd Stock Shareholder Iveric Bio PER mitigated all COI for faculty staff and planners prior to the start of this activity by using a multistep process Off Label Disclosure and Disclaimer This activity may or may not discuss investigational unapproved or off label use of drugs Learners are advised to consult prescribing information for any products discussed The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic treatment or management options for a specific patients medical condition The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Acknowledgment of Support
This activity is supported by an educational grant from Genentech, member of the Roche Group.